U.S. Physical Therapy, Inc. (NYSE:USPH – Get Rating) announced a quarterly dividend on Thursday, August 4th, Zacks reports. Shareholders of record on Thursday, August 18th will be given a dividend of 0.41 per share on Friday, September 16th. This represents a $1.64 dividend on an annualized basis and a yield of 1.81%. The ex-dividend date is Wednesday, August 17th.
U.S. Physical Therapy has a dividend payout ratio of 44.8% meaning its dividend is sufficiently covered by earnings. Equities analysts expect U.S. Physical Therapy to earn $3.69 per share next year, which means the company should continue to be able to cover its $1.64 annual dividend with an expected future payout ratio of 44.4%.
U.S. Physical Therapy Price Performance
Shares of USPH traded down $2.23 during mid-day trading on Friday, hitting $90.49. The company’s stock had a trading volume of 4,082 shares, compared to its average volume of 72,673. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.40. The firm has a 50-day simple moving average of $115.15 and a 200 day simple moving average of $104.76. The firm has a market capitalization of $1.18 billion, a P/E ratio of 31.20 and a beta of 1.22. U.S. Physical Therapy has a 1-year low of $84.43 and a 1-year high of $131.50.
Analysts Set New Price Targets
Separately, TheStreet raised U.S. Physical Therapy from a “c+” rating to a “b-” rating in a research note on Thursday, July 28th. One analyst has rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $121.50.
Hedge Funds Weigh In On U.S. Physical Therapy
Several hedge funds have recently bought and sold shares of USPH. JPMorgan Chase & Co. grew its position in shares of U.S. Physical Therapy by 314.9% in the first quarter. JPMorgan Chase & Co. now owns 63,096 shares of the company’s stock valued at $6,274,000 after purchasing an additional 47,890 shares during the period. Raymond James & Associates purchased a new stake in shares of U.S. Physical Therapy in the first quarter valued at $279,000. Citigroup Inc. grew its position in shares of U.S. Physical Therapy by 3.2% in the first quarter. Citigroup Inc. now owns 11,702 shares of the company’s stock valued at $1,164,000 after purchasing an additional 359 shares during the period. MetLife Investment Management LLC boosted its holdings in U.S. Physical Therapy by 61.1% in the first quarter. MetLife Investment Management LLC now owns 7,102 shares of the company’s stock valued at $706,000 after acquiring an additional 2,693 shares during the last quarter. Finally, Rhumbline Advisers boosted its holdings in U.S. Physical Therapy by 44.9% in the first quarter. Rhumbline Advisers now owns 46,940 shares of the company’s stock valued at $4,668,000 after acquiring an additional 14,547 shares during the last quarter. Hedge funds and other institutional investors own 99.13% of the company’s stock.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
- Get a free copy of the StockNews.com research report on U.S. Physical Therapy (USPH)
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
- BJ’s Wholesale Club Stock Has More Room to Grow
- 3 Hotel Stocks to Consider Checking into After Earnings
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.